Your session is about to expire
← Back to Search
Stress Inoculation Training for Stress
N/A
Waitlist Available
Led By Nathan J Lewis, MD
Research Sponsored by Virginia Commonwealth University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline to up to 3 weeks
Awards & highlights
Study Summary
This trial will test how well medical students learn in high-fidelity simulations of medical settings.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline to up to 3 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to up to 3 weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in anxiety - visual analog
Change in state-trait anxiety
Side effects data
From 2012 Phase 3 trial • 6104 Patients • NCT0134659227%
Injection site pain
25%
Pyrexia
14%
Decreased appetite
14%
Upper respiratory tract infection
14%
Diarrhea
10%
Injection site erythema
9%
Nasopharyngitis
9%
Irritability postvaccinal
9%
Headache
8%
Vomiting
8%
Injection site induration
7%
Myalgia
7%
Hypersomnia
7%
Injection site swelling
7%
Fatigue
6%
Crying
6%
Injection site hemorrhage
4%
Gastroenteritis
1%
Pneumonia
1%
Animal Bite
100%
80%
60%
40%
20%
0%
Study treatment Arm
ATIV (6 to <72 Months)
TIV (6 to <72 Months)
Comparator TIV (6 to <72 Months)
Trial Design
4Treatment groups
Experimental Treatment
Active Control
Group I: Stress management and hands-on trainingExperimental Treatment2 Interventions
an initial brief lecture with both stress management lecture and additional hands-on training
Group II: Stress managementExperimental Treatment1 Intervention
an initial brief lecture with stress management lecture
Group III: Hands-on trainingActive Control1 Intervention
an initial brief lecture with addition hands-on training for the task
Group IV: LectureActive Control1 Intervention
an initial brief lecture with no further training
Find a Location
Who is running the clinical trial?
Virginia Commonwealth UniversityLead Sponsor
699 Previous Clinical Trials
22,885,033 Total Patients Enrolled
Nathan J Lewis, MDPrincipal InvestigatorVirginia Commonwealth University
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You are pregnant.
Research Study Groups:
This trial has the following groups:- Group 1: Stress management and hands-on training
- Group 2: Hands-on training
- Group 3: Lecture
- Group 4: Stress management
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Could additional participants join the experiment at this time?
"Clinicaltrials.gov reports that this clinical trial, which was initially published on August 26th 2021 and last updated November 16th 2022, is not presently recruiting participants. However, there are 143 other active studies accepting volunteers right now."
Answered by AI
Share this study with friends
Copy Link
Messenger